Cargando…

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals in the USA. LDCT has resulted in increased detection of stage I lung cancer for which the current standard of care is surgery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meaney, Claire L., Zingone, Adriana, Brown, Derek, Yu, Yunkai, Cao, Liang, Ryan, Bríd M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522266/ https://www.ncbi.nlm.nih.gov/pubmed/28402963 http://dx.doi.org/10.18632/oncotarget.16784

Ejemplares similares

Serum Inflammatory and Prooxidant Marker Levels in Different Periodontal Disease Stages
por: Andreu, Ricardo, et al.
Publicado: (2021)

Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response
por: Qian, Jia-Yi, et al.
Publicado: (2023)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

Deconvolution Analysis for Classifying Gastric Adenocarcinoma Patients Based on Differential Scanning Calorimetry Serum Thermograms
por: Vega, Sonia, et al.
Publicado: (2015)

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
por: Pradhan, Manohar, et al.
Publicado: (2012)

Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
por: Parker, Amelia L., et al.
Publicado: (2022)

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
por: Eguchi, Takashi, et al.
Publicado: (2016)

Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease
por: Eloueyk, Asmahan K., et al.
Publicado: (2019)

Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma
por: Hinestrosa, Juan Pablo, et al.
Publicado: (2023)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer
por: Ahn, Jung Hwan, et al.
Publicado: (2022)

Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2019)

Assessment of Variability in the SOMAscan Assay
por: Candia, Julián, et al.
Publicado: (2017)

Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma
por: Sun, Yanbin, et al.
Publicado: (2018)

MESOTHELIOMA V/S ADENOCARCINOMA OF LUNG DO SERUM MARKERS HELP?
por: Gupta, Neeraj
Publicado: (2008)

Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis
por: Michalczyk, Anna, et al.
Publicado: (2022)

Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2020)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma
por: Liao, Yu-Cui, et al.
Publicado: (2021)

Microscopical Variables and Tumor Inflammatory Microenvironment Do Not Modify Survival or Recurrence in Stage I-IIA Lung Adenocarcinomas
por: Dell’Amore, Andrea, et al.
Publicado: (2023)

An epigenetic classifier for early stage lung cancer
por: Su, Yun, et al.
Publicado: (2018)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

Associations between overweight/obesity and increased levels of serum inflammatory markers from prodromal stages to chronic psychosis
por: Michalczyk, A., et al.
Publicado: (2023)

Serum markers of apoptosis decrease with age and cancer stage
por: Kavathia, Nilay, et al.
Publicado: (2009)

Serum markers in early-stage and locally advanced melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015)

Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma: A Multicenter, Cohort Study
por: Ren, Lijuan, et al.
Publicado: (2023)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma
por: Guo, Dongming, et al.
Publicado: (2019)

Bilateral Endobronchial Metastasis in Postoperative Stage I Pulmonary Adenocarcinoma
por: Kanzaki, Masato, et al.
Publicado: (2000)

Prognostic relevance of TTF-1 expression in stage I adenocarcinoma
por: Zhou, Chao, et al.
Publicado: (2017)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

Serum leveis of inflammatory markers in type 2 diabetes patients with chronic periodontitis
por: LONGO, Priscila Larcher, et al.
Publicado: (2014)

Diet, Serum Markers and Breast Cancer Mortality in China
por: Guo, Wan‐De, et al.
Publicado: (1994)

Alteration of serum markers in COVID‐19 and implications on mortality
por: Liu, Dan, et al.
Publicado: (2020)

Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China
por: Tan, Qi, et al.
Publicado: (2019)

Taxonomical Evaluation of Plant Chloroplastic Markers by Bayesian Classifier
por: Matiz-Ceron, Luisa, et al.
Publicado: (2022)

A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer
por: Jacob, Havjin, et al.
Publicado: (2018)

Serum inflammatory markers in obese mice: Effect of ghrelin
por: Khazaei, Majid, et al.
Publicado: (2015)

Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3d4sts0nk2cjcn3n6jmn2m1vr9